Ekso Bionics Holdings Inc. (EKSO) NASDAQ

$1.21 (0.07) (-5.47%)

Market Cap: $22.92M

As of 04/18/24 04:00 PM EDT. Market closed.

(EKSO)

Ekso Bionics Holdings Inc. (EKSO)
NASDAQ

$1.21
(0.07) (-5.47%)

Market Cap: $22.92M

As of 04/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative ... read more

since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, ekso bionics is helping people rethink current physical limitations and achieve the remarkable. ekso bionics is headquartered in richmond, california international offices: europe/middle east/africa 29th floor one canada square canary wharf london, united kingdom +44 20 7060 3568 kunden service deutschland +49 89 55067774 read less

COMPANY PROFILE
Sector
Industry
CEO
Jack Peurach
Full Time Employees
116
URL
Address
1414 Harbour Way S Ste 1201, California, Richmond, 94804-3628.
Sector
Industry
CEO
Jack Peurach
Full Time Employees
116
Address
1414 Harbour Way S Ste 1201, California, Richmond, 94804-3628.
PRICE CHART FOR EKSO BIONICS HOLDINGS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.24
Previous Close
$1.28
Days Range
$1.25 - $1.35
52 week range
$0.62 - $3.13
Volume
180,208
Avg. Volume (30 days)
112,626
Market Cap
$22.92M
Dividend Yield
-
P/E
-
Shares Outstanding
17,903,128
Open
$1.24
Previous Close
$1.28
Days Range
$1.25 - $1.35
52 week range
$0.62 - $3.13
Volume
180,208
Avg. Volume (30 days)
112,626
Market Cap
$22.92M
Dividend Yield
-
P/E
-
Shares Outstanding
17,903,128
FINANCIAL STATEMENTS FOR EKSO BIONICS HOLDINGS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR EKSO BIONICS HOLDINGS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Lathan CorinnaDirectorAug 23, 2023 Buy$0.955,5005,222143,958Mar 14, 2024, 06:41 PM
Lathan CorinnaDirectorAug 10, 2023 Buy$1.254,2015,251138,458Mar 14, 2024, 06:41 PM
Lathan CorinnaDirectorNov 02, 2023 Buy$1.244,0325,005147,990Mar 14, 2024, 06:41 PM
Davis Scott G.President & COOAug 17, 2023 Sale$1.0037,44637,281331,372Aug 18, 2023, 09:44 PM
Wong JeromeChief Financial OfficerAug 17, 2023 Sale$1.0012,78412,728266,953Aug 18, 2023, 09:40 PM
SHERMAN STEVENExecutive ChairMay 24, 2023 Sale$1.4445,66065,874364,913May 26, 2023, 06:45 PM
Jones Jason CChief Operating OfficerMay 08, 2023 Sale$1.573,4355,401138,554May 17, 2023, 07:42 PM
SHERMAN STEVENExecutive ChairDec 04, 2022 Sale$1.2810,57613,492728,664Dec 07, 2022, 09:09 PM
SHERMAN STEVENCEO & ChairmanNov 21, 2022 Sale$1.265,7877,312708,042Nov 23, 2022, 03:17 PM
Jones Jason CSenior VP Product DevelopmentNov 16, 2022 Sale$1.287821,003124,982Nov 17, 2022, 05:49 PM
Wong JeromeChief Financial OfficerNov 16, 2022 Sale$1.28723927101,469Nov 17, 2022, 05:47 PM
SHERMAN STEVENCEO & ChairmanOct 24, 2022 Sale$1.295,9217,619698,230Oct 26, 2022, 06:31 PM
SHERMAN STEVENCEO & ChairmanSep 22, 2022 Sale$1.756,04310,553688,551Sep 26, 2022, 07:20 PM
Jones Jason CSenior VP Product DevelopmentAug 31, 2022 Sale$2.315,87313,587125,764Sep 02, 2022, 05:50 PM
SHERMAN STEVENCEO & ChairmanAug 22, 2022 Sale$2.205,57212,278678,995Aug 23, 2022, 03:09 PM
Wong JeromeInterimChief Financial OfficerAug 03, 2022 Sale$1.801,6753,021102,192Aug 04, 2022, 07:56 PM
SHERMAN STEVENCEO & ChairmanJul 25, 2022 Sale$1.755,6629,909668,968Jul 25, 2022, 08:27 PM
Wong JeromeInterimChief Financial OfficerJul 18, 2022 Sale$1.7198167103,867Jul 20, 2022, 04:01 PM
Davis Scott G.President & COOJun 30, 2022 Sale$1.724,9978,595368,818Jul 05, 2022, 09:39 PM
SHERMAN STEVENCEO & ChairmanJun 22, 2022 Sale$1.745,3309,259659,031Jun 22, 2022, 08:14 PM
SHERMAN STEVENCEO & ChairmanJun 15, 2022 Sale$1.906,91113,118648,762Jun 17, 2022, 08:22 PM
SHERMAN STEVENCEO & ChairmanMay 24, 2022 Sale$1.766,59711,605637,408May 26, 2022, 08:32 PM
SHERMAN STEVENCEO & ChairmanApr 28, 2022 Sale$2.416,86216,521628,406May 02, 2022, 05:28 PM
Davis Scott G.President & COOApr 20, 2022 Sale$2.624,04310,58373,815Apr 26, 2022, 05:13 PM
GLENN JOHNChief Financial OfficerMar 22, 2022 Sale$2.823,4629,76235,130Mar 28, 2022, 04:52 PM
Jones Jason CVP of Product DevelopmentMar 22, 2022 Sale$2.823,2659,20681,637Mar 28, 2022, 04:44 PM
SHERMAN STEVENCEO & ChairmanMar 24, 2022 Sale$2.946,38918,784619,669Mar 25, 2022, 08:53 PM
SHERMAN STEVENCEO & ChairmanMar 15, 2022 Sale$2.605,96515,508610,459Mar 17, 2022, 05:19 PM
Wang Theodore TDirectorJan 16, 2020 Option Exercise$0.4519,4458,75038,624Jan 21, 2020, 08:58 PM
Stern StanleyDirectorJan 16, 2020 Option Exercise$0.4527,77812,50027,778Jan 21, 2020, 05:40 PM
Hamilton MarilynDirectorJan 16, 2020 Option Exercise$0.4522,22310,00050,795Jan 21, 2020, 04:39 PM
SCHRECK THOMAS ADirectorJan 16, 2020 Option Exercise$0.4534,72315,62534,723Jan 21, 2020, 04:35 PM
Li KechengDirectorJan 16, 2020 Option Exercise$0.4526,38911,87526,389Jan 21, 2020, 04:33 PM
Peurach JackChief Executive OfficerMay 31, 2019 Sale$1.3731,43743,06978,120Jun 19, 2019, 01:56 PM
Jones Jason CVP of Product DevelopmentMay 31, 2019 Sale$1.319,43012,3533,070Jun 19, 2019, 01:53 PM
GLENN JOHNChief Financial OfficerMay 31, 2019 Sale$1.3710,29214,1004,708Jun 19, 2019, 01:48 PM
Wang Theodore TDirectorAug 03, 2018 Option Exercise$1.7919,17934,33019,179Aug 07, 2018, 09:05 PM
Peurach JackChief Executive OfficerAug 03, 2018 Option Exercise$1.7911,33320,28659,557Aug 07, 2018, 03:43 PM
DeLonzor RussVice Pres., OperationsMay 10, 2018 Option Exercise$1.511,2701,91216,512Jun 08, 2018, 04:33 PM
SCHEDER-BIESCHIN MAXChief Financial OfficerMay 10, 2018 Option Exercise$1.514,1516,24876,959Jun 08, 2018, 04:29 PM
SHERMAN STEVENDirectorMay 23, 2018 Buy$1.51200,000301,550400,825May 25, 2018, 05:07 PM
Davault GregoryVice Pres., Global MarketingMar 23, 2018 Option Exercise$1.538,65513,20017,235Mar 27, 2018, 05:16 PM
DeLonzor RussVice Pres., OperationsMar 23, 2018 Option Exercise$1.529,40014,25014,969Mar 27, 2018, 05:13 PM
Angold RussPresident, EksoWorksMar 23, 2018 Option Exercise$1.513,9766,005397,669Mar 27, 2018, 05:09 PM
SCHEDER-BIESCHIN MAXChief Financial OfficerMar 23, 2018 Option Exercise$1.5417,83627,48271,860Mar 27, 2018, 05:05 PM
Angold RussPresident, EksoWorksNov 22, 2017 Sale$3.5150,000175,500391,326Nov 27, 2017, 04:12 PM
Peurach JackDirectorSep 14, 2017 Buy$1.2720,00025,40048,224Sep 18, 2017, 06:47 PM
Wendell Amy McBrideDirectorSep 14, 2017 Buy$1.2316,26420,00516,264Sep 15, 2017, 05:05 PM
Looby ThomasPresident & CEOSep 08, 2017 Buy$1.1315,00016,95020,315Sep 12, 2017, 06:47 PM
SCHEDER-BIESCHIN MAXChief Financial OfficerSep 07, 2017 Buy$1.1310,00011,30032,371Sep 08, 2017, 01:26 PM
Looby ThomasPresident & CEOAug 31, 2017 Option Exercise$1.003,7143,7145,315Sep 05, 2017, 09:05 PM
Davault GregoryVice Pres., Global MarketingAug 31, 2017 Option Exercise$1.001,8291,8293,258Sep 05, 2017, 06:21 PM
SCHEDER-BIESCHIN MAXChief Financial OfficerAug 31, 2017 Option Exercise$1.0012,55412,55422,371Sep 05, 2017, 06:19 PM
Angold RussPresident, EksoWorksAug 31, 2017 Option Exercise$1.00200,000200,000441,326Sep 05, 2017, 06:18 PM
Peurach JackDirectorAug 31, 2017 Option Exercise$1.0015,16215,16228,224Sep 05, 2017, 06:16 PM
Boren DanielDirectorAug 31, 2017 Option Exercise$1.006,6346,6349,492Sep 05, 2017, 06:15 PM
Angold RussPresident, EksoWorksAug 23, 2017 Sale$1.339,35212,438241,326Aug 25, 2017, 06:09 PM
Angold RussPresident, EksoWorksAug 16, 2017 Sale$1.5328,25443,229250,678Aug 18, 2017, 05:00 PM
Angold RussPresident, Ekso LabsAug 15, 2017 Sale$1.5950,00079,500278,932Aug 15, 2017, 06:37 PM
Angold RussPresident, Ekso LabsAug 14, 2017 Sale$1.5971,746114,076328,932Aug 15, 2017, 06:37 PM
Angold RussPresident, Ekso LabsAug 11, 2017 Sale$1.50100,000150,000400,678Aug 15, 2017, 06:37 PM
SCHEDER-BIESCHIN MAXChief Financial OfficerNov 11, 2016 Buy$3.991,0003,9959,817Nov 15, 2016, 02:36 PM
Looby TomPresident & CEONov 11, 2016 Buy$3.981,0003,9831,600Nov 15, 2016, 02:06 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Lathan CorinnaDirector08/23/20235,222
Lathan CorinnaDirector08/10/20235,251
Lathan CorinnaDirector11/02/20235,005
Davis Scott G.President & COO08/17/202337,281
Wong JeromeChief Financial Officer08/17/202312,728
SHERMAN STEVENExecutive Chair05/24/202365,874
Jones Jason CChief Operating Officer05/08/20235,401
SHERMAN STEVENExecutive Chair12/04/202213,492
SHERMAN STEVENCEO & Chairman11/21/20227,312
Jones Jason CSenior VP Product Development11/16/20221,003
Wong JeromeChief Financial Officer11/16/2022927
SHERMAN STEVENCEO & Chairman10/24/20227,619
SHERMAN STEVENCEO & Chairman09/22/202210,553
Jones Jason CSenior VP Product Development08/31/202213,587
SHERMAN STEVENCEO & Chairman08/22/202212,278
Wong JeromeInterimChief Financial Officer08/03/20223,021
SHERMAN STEVENCEO & Chairman07/25/20229,909
Wong JeromeInterimChief Financial Officer07/18/2022167
Davis Scott G.President & COO06/30/20228,595
SHERMAN STEVENCEO & Chairman06/22/20229,259
SHERMAN STEVENCEO & Chairman06/15/202213,118
SHERMAN STEVENCEO & Chairman05/24/202211,605
SHERMAN STEVENCEO & Chairman04/28/202216,521
Davis Scott G.President & COO04/20/202210,583
GLENN JOHNChief Financial Officer03/22/20229,762
Jones Jason CVP of Product Development03/22/20229,206
SHERMAN STEVENCEO & Chairman03/24/202218,784
SHERMAN STEVENCEO & Chairman03/15/202215,508
Wang Theodore TDirector01/16/20208,750
Stern StanleyDirector01/16/202012,500
Hamilton MarilynDirector01/16/202010,000
SCHRECK THOMAS ADirector01/16/202015,625
Li KechengDirector01/16/202011,875
Peurach JackChief Executive Officer05/31/201943,069
Jones Jason CVP of Product Development05/31/201912,353
GLENN JOHNChief Financial Officer05/31/201914,100
Wang Theodore TDirector08/03/201834,330
Peurach JackChief Executive Officer08/03/201820,286
DeLonzor RussVice Pres., Operations05/10/20181,912
SCHEDER-BIESCHIN MAXChief Financial Officer05/10/20186,248
SHERMAN STEVENDirector05/23/2018301,550
Davault GregoryVice Pres., Global Marketing03/23/201813,200
DeLonzor RussVice Pres., Operations03/23/201814,250
Angold RussPresident, EksoWorks03/23/20186,005
SCHEDER-BIESCHIN MAXChief Financial Officer03/23/201827,482
Angold RussPresident, EksoWorks11/22/2017175,500
Peurach JackDirector09/14/201725,400
Wendell Amy McBrideDirector09/14/201720,005
Looby ThomasPresident & CEO09/08/201716,950
SCHEDER-BIESCHIN MAXChief Financial Officer09/07/201711,300
Looby ThomasPresident & CEO08/31/20173,714
Davault GregoryVice Pres., Global Marketing08/31/20171,829
SCHEDER-BIESCHIN MAXChief Financial Officer08/31/201712,554
Angold RussPresident, EksoWorks08/31/2017200,000
Peurach JackDirector08/31/201715,162
Boren DanielDirector08/31/20176,634
Angold RussPresident, EksoWorks08/23/201712,438
Angold RussPresident, EksoWorks08/16/201743,229
Angold RussPresident, Ekso Labs08/15/201779,500
Angold RussPresident, Ekso Labs08/14/2017114,076
Angold RussPresident, Ekso Labs08/11/2017150,000
SCHEDER-BIESCHIN MAXChief Financial Officer11/11/20163,995
Looby TomPresident & CEO11/11/20163,983
Load More Insider Transactions
FUNDS WITH A POSITION IN EKSO BIONICS HOLDINGS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC98,4550.00003%No changeOther
RENAISSANCE TECHNOLOGIES LLC80,0160.00031%16.44%Other
BLACKROCK INC.55,4530%No changeOther
CHANGE IN SHARES OUTSTANDING FOR EKSO BIONICS HOLDINGS INC
STOCK BUYBACKS FOR EKSO BIONICS HOLDINGS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
2.69%
1Q
12/31/2023
06/30/2023
5.98%
2Q
12/31/2023
03/31/2023
8.69%
3Q
12/31/2023
12/31/2022
9.82%
4Q
12/31/2023
09/30/2022
10.57%
5Q
12/31/2023
06/30/2022
12.17%
6Q
12/31/2023
03/31/2022
13.54%
7Q
12/31/2023
12/31/2021
14.00%
8Q
12/31/2023
09/30/2021
13.71%
9Q
12/31/2023
06/30/2021
13.46%
10Q
12/31/2023
03/31/2021
34.41%
11Q
12/31/2023
12/31/2020
76.91%
12Q
12/31/2023
09/30/2020
72.48%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
2.69%
1Q
06/30/2023
5.98%
2Q
03/31/2023
8.69%
3Q
12/31/2022
9.82%
4Q
09/30/2022
10.57%
5Q
06/30/2022
12.17%
6Q
03/31/2022
13.54%
7Q
12/31/2021
14.00%
8Q
09/30/2021
13.71%
9Q
06/30/2021
13.46%
10Q
03/31/2021
34.41%
11Q
12/31/2020
76.91%
12Q
09/30/2020
72.48%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR EKSO BIONICS HOLDINGS INC
LOADING...